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ABSTRACT
Objective. This study has two main 
aims, firstly to define subgroups of 
women affected by fibromyalgia syn-
drome (FMS) based on symptoms and 
secondly to determine cardiovascular 
parameters in treadmill exercises in 
order to prescribe physical activity. 
Methods. Thirty-two women (age= 
53.26±6.61yr) were assigned to two dif-
ferent groups based on their functional 
capacity and symptoms as measured 
by the Fibromyalgia Impact Question-
naire and pain. Subjects were submit-
ted twice to a maximum treadmill incre-
mental test until participants achieved 
volitional exhaustion (VO2max). Expired 
respiratory gases, ventilator param-
eters and heart rate (HR) were meas-
ured continuously through exercise, 
and rate perceived exertion (RPE) was 
assessed once a minute during the test. 
Results. Peak VO2 values for the 
moderately affected group (Group 1) 
were significantly different from those 
of severely affected group (Group 2) 
(26.2±2.1 ml•kg-1•min-1 (Group 1) 
and 22.1±2.5 ml•kg-1•min-1 (Group 
2)). Additionally taking into account 
VO2 at ventilatory threshold (VO2VT), 
significant differences between groups 
were found in both tests. Some notable 
differences in all parameters evaluated 
were also found. 
Conclusion. This study has demon-
strated that the aerobic capacity of pa-
tients with FMS was different according 
to how severely affected they were by 
the condition; therefore, physical activ-
ity of the same intensity should not be 
prescribed for both groups. According 
to these results, health professionals 
could prescribe physical activity with 
confidence to this patient group.
Introduction
Fibromyalgia (FMS) is a condition 
characterised by widespread pain and 
pain at specific tender points (1). The 
prevalence of FMS in Spain is 2.7%, 
affecting women much more frequently 
than men, with a ratio of 20:1 (2). Fi-
bromyalgia may be a syndrome of dys-
functional central pain processing, and 
the neurologic mechanisms responsible 
for maintaining central pain states are 
now being studied, although the patho-
genesis of widespread pain and FMS 
is unknown. Altered responses from 
the hypothalamus-pituitary-adrenal axis, 
changes in pain modulation in the central 
nervous system, sympathetic nervous 
system and muscular system have been 
suggested as being of importance (3). 
Several studies have evaluated exercis-
es for the management of patients with 
FMS, the majority evaluating aerobic 
fitness by itself or combined with other 
modalities and, although treatment op-
tions for FMS are limited, a growing 
body of evidence suggests that exercise 
is beneficial (4-6).
While FMS is a chronic disease, some 
work has demonstrated symptomatic 
improvement in patients who practice 
regular physical exercise, as part of a 
prescribed rehabilitation programme 
(4-7). The acquisition of physical ex-
ercise as a coping strategy has been 
shown to be effective in improving 
pain and aerobic fitness (8). However, 
in order for the exercise to be effec-
tive, it has to be carefully prescribed 
and controlled. Exercise intensity has 
to be such that it can induce the effects 
of training but not so high as to increase 
symptoms. Getting patients with FMS 
to initiate and maintain an exercise pro-
gramme remains challenging. In order 
to prescribe exercise to improve physi-
cal fitness, suitable frequency, duration 
and intensity are needed, among these, 
intensity is the most difficult to control 
(9). There are difficult problems when 
prescribing physical activity for wom-
en with FMS. Two women of the same 
age would have the same theoretical 
maximal heart rate (HRmax) according 
to traditional prescriptions based on the 
formula 220–age supported by numer-
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ous authors (10-14). This can result in 
women with very different symptom 
profiles being prescribed similar ex-
ercise interventions, which may result 
in significantly different outcomes for 
patients who experience these similar 
interventions. Addressing these issues 
will assist clinicians design optimal 
therapeutic exercise training programs 
for patients. 
Although 80% of patients with FMS 
are considered below normal level for 
maximum oxygen uptake (VO2max), ac-
cording to the American Heart Associa-
tion (AHA) standards (15,16), no trials 
had been done so far to measure aerobic 
fitness, directly by a espiroergometric 
test and aerobic threshold, taking into 
account the different types of symp-
toms and capacities in patients.
The aim of this work was to identify 
changes in physiological parameters 
produced in patients with FMS while 
they exercise, while taking account of 
how severely affected they are by their 
condition. This paper assesses the na-
ture and magnitude of differences in 
submaximal and maximal exercise ca-
pacity in women with FMS, assigned 
to two different groups according to 




Thirty-two women with FMS between 
42 and 63 years old participated in the 
study. Participants were assigned, based 
on their symptom levels as defined by 
the Fibromyalgia Impact Questionnaire 
(FIQ). Subjects with a baseline FIQ be-
low the overall baseline median of 54 
were allocated in Group1 and those with 
baseline FIQ equal to or higher than 54 
to Group 2 (Group1=52.75±5.99 yrs; 
Group 2=55.37±7.22 yrs); represent-
ing two natural groups according to Da 
Costa et al. (17). The exclusion criteria 
included the presence of inflammatory 
rheumatic diseases and subjects with 
respiratory or cardiovascular diseases 
that prevented physical exercise were 
also omitted. Finally, those women 
with FMS who attended a physical 
therapy during the last six months were 
excluded to avoid possible interactions 
with the present trial. The Committee 
on Biomedical Ethics of the University 
of Seville (Spain) gave approval for the 
study.
Outcome measures
The primary outcome measures were 
physical fitness and symptoms as meas-
ured by the FIQ, visual analogue scale 
(VAS) for pain, Tender Points (TPs), 
and aerobic capacity. 
Health related-quality of life and pain
All patients had to complete several 
questionnaires about their perceived 
functional ability and quality of life. 
The Spanish version of the FIQ, is a dis-
ease-specific measure of global health 
status developed and validated for use 
in patients with FMS (18). Total scores 
range from 0 to 100, with higher scores 
indicating more severe symptoms and 
disability. Pain intensity over the past 
week was assessed by using self-re-
port using 10 cm VAS, 0=no pain and 
10=severe pain (19). According to the 
protocol described by Wolfe et al. (1), 
the number of TPs were recorded.
Physiological parameters
Expired gas analysis was performed 
with a computerised metabolic system 
MetaMax 3B (CORTEZ Biophysik 
GMBH, Germany). From this analysis 
the following variables were evaluated: 
the rate at which gas enters/leaves the 
lung or ventilation per minute (VE), 
the volume of carbon dioxide expired 
from the lungs or carbonic gas output 
(VCO2), the respiratory quotient (RQ) 
calculated from the ratio CO2 eliminated/
O2 consumed and ventilatory efficiency 
will be assessed using the ventilatory 
equivalents of CO2 and O2 (VE/VCO2 
and VE/VO2).
The highest value obtained in the 
load was taken as peak oxygen uptake 
(VO2peak). Heart rate (HR) was record-
ed via heart rate monitor (Polar; Seat-
tle, WA). Rating of perceived exertion 
(RPE) was collected using the Borg 6-
20 Scale, based on the physical sensa-
tions a person experiences during phys-
ical activity, including increased heart 
rate, increased respiration or breathing 
rate, increased sweating, and muscle 
fatigue were recorded in both trials.
The level of physical activity over the 
previous seven days was assessed using 
a self-administered short form of the 
International Physical Activity Ques-
tionnaire (IPAQ). The questionnaire 
allows individuals to be classified into 
one of three groups including inactive, 
minimally active and active. Minutes 
of sitting, walking, moderate-intensity 
(walking not included), and vigorous-
intensity activities were computed for 
the previous week.
Testing protocols
After informed written consent was ob-
tained, subjects were submitted twice to 
a maximum treadmill incremental test to 
assess the reproducibility of the physi-
ological outcome measures and testing 
protocols were performed approximate-
ly one week apart. The Bruce Protocol, 
modified by Kaminsky (20) was used. 
The protocol begins at 1.7 mph and at 
an incline of 10% and consists of in-
crements in either speed and/or grade 
every 20 seconds. The speed and grade 
settings for the last 20 seconds of each 
3-minute segment of the protocol are 
identical to those of the standard Bruce 
protocol (e.g. 3 minutes: 1.7 mph, 10% 
grade). During both treadmill bouts, ex-
pired gases were continuously collected 
breath by breath. HR was measured and 
recorded each five seconds during the 
exercise. 
Once given anchors of RPE, each sub-
ject warmed up for 5 minutes before the 
test. The duration of each stage of the 
test was 3 min. Rate of Perceived Ex-
ertion was recorded every minute dur-
ing exercise, and VE, RQ, HR and VO2 
were recorded every 5 seconds. Criteria 
for reaching VO2max included two of the 
following: 1) respiratory exchange ra-
tio=1.0, 2) HRmax=95% of age-predicted 
maximum, and 3) plateau or decrease of 
VO2 (2ml·kg-1·min-1) during the final 
minute of the stage. Anaerobic thresh-
old (VT) was defined by using the fol-
lowing criteria: nonlinear VE elevation, 
VE/VO2, VE/VCO2, and RQ curves in-
flection points.
Data were averaged every 30 seconds, 
and they were used to calculate VO2, 
RR, VE and RQ. Peak oxygen up-
take was expressed in absolute values 
(VO2peak, l//min) and relative to body 
weight (ml·kg-1·min-1).
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Statistical analysis
Descriptive data for perceptual and 
physiological variables were calculated 
as mean±SD. All variables were com-
pared in both groups using independ-
ent t-test. Data were tested for normal 
distribution (Kolmogorov-Smirnov 
non-parametric test). In all tests the 
significance level was set at p<0.05. 
Analyses were performed using SPSS 
15.0 for windows (SPSS Inc, Chicago, 
IL, USA). 
Results
The main personal features of patients 
in both groups are presented in Table I. 
According to the IPAQ scoring mecha-
nism 68.75% of patients in group one 
and 93.75% of the patients allocated in 
group two were considered as inactive 
(do not meet 3 or more days of vigorous 
activity of at least 20 minutes per day, 
or 5 or more days of moderate-intensity 
activity or walking of at least 30 min-
utes per day), and just 31.25% in group 
one and 6.25% in group two reported to 
walk of at least 30 minutes per day and 
therefore were considered as moderate 
active. Both groups (allocation based 
on their level of FMS severity) showed 
significant differences related to their 
symptoms, functional ability (FIQ and 
VAS) and TPs.
Sixty-three percent of participants in 
Group 1 and only 40% in Group 2 
reached VO2max. All patients in both 
groups reached anaerobic threshold load 
(VO2VT). VO2max and VO2VT were lower 
in Group 2, when compared to Group 1. 
Oxygen utilisation percentage at anaer-
obic threshold in relation to maximum 
uptake (%VT) was higher in Group 2 
(Table II). 
Peak VO2 values for Group1 were sig-
nificantly higher from those reached in 
Group 2 (26.2±2.1 ml·kg-1·min-1 (Gr1) 
and 22.1±2.5 ml·kg-1·min-1(Gr2)). 
On the other hand, taking into account 
VO2VT, significant differences between 
groups were found only in the second 
trial. Another finding is that achieved 
HRmax, VE and RPE were all lower in 
group 2, i.e. those who had the worst 
symptoms. Finally, significant differ-
ences in test duration (815 seconds in 
Group 1, and 627 seconds in Group 2) 
were found.
Discussion
According to Thieme et al. (21), many 
studies in FMS report negative finding 
without considering sub-groups in FMS. 
The consequences of this may be that 
positive treatment intervention may be 
overlooked. The aim of this study was 
to use cardiovascular parameters and 
symptom severity to prescribe physi-
cal activity in women with FMS. In the 
present study those participants with 
more severe symptoms had lower VO2 
and higher HR, than patients with less 
severe symptoms. In order to determine 
whether a VO2max value is abnormally 
low, reference values are required. This 
allows those values to be compared 
with that published by ACSM (22). 
Participants in Group 1 scored in the 
35th percentile (26.13 ml.kg-1.min-1); 
by contrast Group 2 patients were under 
10% (22.33 ml.kg-1.min-1). This study 
has demonstrated that there were sig-
nificant statistical differences between 
Table I. Subjects’ characteristics.
 
     Group 1        Group 2
 
 Mean SD Mean SD
Age (years) 54.12 5.94 55.38 7.37
BMI (kg/m2) 28.29 4.49 29.04 4.98
VAS pain (0-10) 5.6 1.9 6.4 2.3
FIQ (0-100) 51.56 12.46 70.21 5.75
TP 11.71 4.61 14.88 3.36
Group 1: moderately affected; Group 2: severely affected.
BMI: body mass index; FIQ: Fibromyalgia Impact Questionnaire; TP: tender points count. 
Table II. Physiological parameters mean ± standard deviation. 
 
 Trial 1 Trial 2
Variables Group 1 Group 2 p-values Group 1 Group 2 p-values
RR 27.95 ± 5.50 26.68 ± 6.75 0.372 25.32 ± 5.16 26.16 ± 8.21 0.748
VE 36.58 ± 5.55 35.61 ± 5.15 0.598 34.29 ± 5.93 32.22 ± 7.07 0.291
VO2 (l/min) 1.31 ± 0.19 1.28 ± 0.21 0.825 1.27 ± 0.06 1.23 ± 0.27 0.453
VO2 (ml•kg-1•min-1) 20.72 ± 2.15 16.08 ± 1.55 <0.001* 19.98 ± 1.72 15.17 ± 1.46 <0.001*
VO2peak 26.17 ± 3.62 22.13 ± 2.50 <0.001* 23.59 ± 2.83 20.89 ± 1.62 <0.001*
VO2VT 20.28 ± 2.70 19.21 ± 2.22 0.163 20.29 ± 3.04 18.55 ± 1.67 0.019*
RQ 0.91 ± 0.01 0.91 ± 0.01                   NS 0.89 ± 0.10 0.89 ± 0.05                  NS
HRmean 130.82 ± 12.34 126.03 ± 16.81 0.311 129.91 ± 13.26 123.21 ± 15.98 0.135
HRmax 158.17 ± 12.37 144.01 ± 21.33 0.015* 153.88 ± 10.76 145.11 ± 19.92 0.086
HRVT 140.33 ± 16.62 131.64 ± 22.76 0.177 138.35 ± 11.84 133.11 ± 16.39 0.243
RPE 13.6 ± 0.87 14.22 ± 1.20 0.049* 13.42 ± 0.63 14.31 ± 0.71 <0.001*
Duration (s) 815 ± 23 627 ± 16 <0.001* 818 ± 6 621 ± 9 <0.001*
Group1: moderately affected group; Group 2: severely affected group. RR: respiratory rate; VE: ventilation per minute; RQ: respiratory quotient; VO2peak: 
maximun oxygen uptake reached on the test; VO2VT: oxygen uptake at ventilatory threshold; HR: Heart rate; HRVT: heart rate at ventilatory threshold; 
RPE: rating of perceived exertion. p<0.05.
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patients with FMS in VO2max based on 
their symptoms. This confirms low car-
diorespiratory fitness level in patients 
with the worst symptoms as previously 
described (16, 23, 24). 
This study has also shown that FMS 
patients had greater perceived exertion, 
which can be due to prolonged inactiv-
ity in these patients (25). In contrast to 
healthy subjects, women with FMS per-
ceive modest muscular work as painful, 
which may be caused by altered pain 
processing mechanisms (26). Some pa-
tients can exercise at moderate intensi-
ty, while for others this intensity can in-
crease their pain (10). It has been dem-
onstrated that pain intensity in those with 
chronic pain is not constant, particularly 
in those with FMS whose symptoms are 
highly variable (27). This emphasises 
the need to assess individual capacity 
before starting any exercise program 
in those with FMS. A significant asso-
ciation between perceived exertion and 
pain was found, which could indicate 
that it is difficult to distinguish between 
pain and perceived exertion during this 
type of exercise. Sensitisation of ergore-
ceptors and nociceptors in the muscles 
has been suggested as an explanation of 
both higher perceived exertion and pain 
in FMS compared with controls at simi-
lar workloads (28). The attenuated hor-
monal response to exercise in FMS pa-
tients may indicates lower sympathetic 
activity during exercise which is related 
with pain sensation. However, aerobic 
capacity is a known confounder of sym-
pathoadrenal responses and differences 
in exercise intensity may affect the cate-
cholamine release (3). Reduction in the 
release of several neurotransmitters is 
thought to play a role in pain processing 
in FMS patients and both pain and exer-
cise appear to modify the corticomotor 
pathway; although the relation between 
activation of the corticomotor pathway 
and exercise-induced analgesia is not 
known (29). One potential mechanism 
is the activation of the opioid system, 
which is frequently assessed in relation 
to exercise-induced analgesia and acti-
vated with exercise, when physical fit-
ness is high circulating beta–endorphin 
is increased (30).
Sietsema (23) found no differences be-
tween those with FMS and sedentary 
control individuals by using VO2peak 
and VO2VT;. However, Valim et al. (16), 
showed lower VO2max and VO2VT val-
ues in FMS patients compared to con-
trols. VO2 values were slightly lower in 
Group 1, than VO2 values previously 
reported for sedentary women (31), 
although VO2VT values were within 
normal range for sedentary subjects. 
By contrast, VO2 for Group 2 patients 
showed significant differences, similar 
to that reached in other diseases (32).
A notable finding in the present study 
was the difficulty in obtaining a true 
maximal exercise test in some of those 
with FMS; however all patients in both 
groups reached the anaerobic thresh-
old load. Thus, VT can be considered 
a more reliable index than maximum 
uptake in patients with FMS (15). In 
this sense, VT can be used directly and 
accurately as a cardiorespiratory fit-
ness measure (33), and is also a useful 
means to evaluate training effect in low 
to moderate intensity physical exercise 
(34) as recommended in these patients 
(6). The exercise intensity is important 
for the safety and effectiveness of pro-
grams in subjects with FMS (35). How-
ever, the patient must be aware that at 
short term could increase the pain and 
fatigue. Heartbeat at VT indicates a 
training intensity suitable to gain car-
dio-respiratory fitness, with a lower risk 
of injury and higher adherence (36).
In summary, results confirmed the ne-
cessity of establishing sub-groups in 
FMS patients based on symptoms and 
cardiovascular parameters in order to 
prescribe physical activity. This study 
also demonstrated that aerobic capacity 
of FMS patients is different according 
to how severe the condition is. This in-
formation may be used for prescription 
and control of physical activity in these 
populations. Prescription of aerobic 
exercise based on anaerobic threshold 
may be recommend in FMS patients 
instead of VO2max-
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